RxSight, Inc. Common Stock (RXST) is a publicly traded Healthcare sector company. As of August 25, 2026, RXST trades at $6.27 with a market cap of $259.96M and a P/E ratio of -6.63. RXST moved +0.24% today. Year to date, RXST is -39.92%; over the trailing twelve months it is -32.54%. Its 52-week range spans $4.48 to $37.13. Analyst consensus is neutral with an average price target of $7.79. Rallies surfaces RXST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for RXST shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $6.27 |
| Market Cap | $259.96M |
| P/E Ratio | -6.63 |
| EPS | $-0.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $37.13 |
| 52-Week Low | $4.48 |
| Volume | 145.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $134.48M |
| Net Income | $-38.94M |
| Gross Margin | 76.60% |
10 analysts cover RXST: 0 strong buy, 1 buy, 7 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $7.79.